No one with HIV should die from tuberculosis
Authors:
- 1 December 2015
- journal article
- Published by Elsevier in The Lancet
- Vol. 386 (10010) , e48-e50
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trialThe Lancet Infectious Diseases, 2013
- Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-AnalysisPLOS Medicine, 2012
- Screening Strategies for Tuberculosis Prevalence Surveys: The Value of Chest Radiography and SymptomsPLOS ONE, 2012
- Integration of HIV and TB Services Results in Improved TB Treatment Outcomes and Earlier Prioritized ART Initiation in a Large Urban HIV Clinic in UgandaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Timing of Antiretroviral Therapy for HIV-1 Infection and TuberculosisNew England Journal of Medicine, 2011
- Assessing Tuberculosis Case Fatality Ratio: A Meta-AnalysisPLOS ONE, 2011
- Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resourcesThe Lancet Infectious Diseases, 2010
- The HIV-associated tuberculosis epidemic—when will we act?The Lancet, 2010
- Timing of Initiation of Antiretroviral Drugs during Tuberculosis TherapyNew England Journal of Medicine, 2010
- Tuberculosis in New York City — Turning the TideNew England Journal of Medicine, 1995